Related by context. Frequent words. (Click for all words.) 71 efficacy 70 tolerability 70 pharmacokinetic profile 68 active comparator 68 diabetic neuropathic pain 68 tolerability profile 67 placebo controlled clinical 67 rHuPH# 66 dose regimens 66 pharmacodynamic 66 LEVADEX 66 Tolerability 65 placebo controlled studies 65 noninferiority 65 Pharmacokinetic 65 prospective randomized controlled 65 achieved statistical significance 64 Azedra 64 ciclesonide 64 tipranavir 64 serum concentrations 64 pharmacodynamics 64 bosentan 64 administered subcutaneously 64 dosing regimens 64 MAP# 64 nab paclitaxel 64 alvimopan 64 pharmacokinetics 64 Gabapentin GR 64 tezampanel 63 antitumor activity 63 esomeprazole 63 safety tolerability pharmacokinetics 63 tiotropium 63 #mg dose [003] 63 adalimumab 63 Phase 1b trial 63 pharmacokinetic properties 63 plus prednisone 63 teduglutide 62 ziprasidone 62 tolerated dose MTD 62 elagolix 62 dabigatran etexilate 62 double blinded placebo 62 mg QD 62 PROMACTA 62 pharmacokinetic 62 antithrombotic 62 DAVANAT 62 6R BH4 62 Efficacy 62 Fidaxomicin 62 randomized controlled clinical 62 LIALDA 61 secondary efficacy endpoints 61 NGX# 61 decitabine 61 mg dose 61 teriparatide 61 ketoconazole 61 Phase IIa trial 61 CA4P 61 pregabalin 61 primary efficacy endpoints 61 topical formulation 61 lacosamide 61 tobramycin 61 virologic response 61 placebo controlled trials 61 SCH # 61 pramipexole 61 randomized controlled clinical trials 61 inflammatory lesions 61 octreotide 61 intra articular 61 FOSRENOL R 60 COPAXONE R 60 febuxostat 60 LY# [003] 60 oral bioavailability 60 PXD# 60 etanercept 60 safety tolerability 60 fluticasone propionate 60 BAY #-# 60 mg kg dose 60 glatiramer acetate 60 tocilizumab 60 non inferiority 60 Phase 2a trial 60 Cmax 60 pseudobulbar affect PBA 60 vasomotor symptoms 60 mg BID 60 systemic absorption 60 Phase 2b study 60 tanespimycin 60 Pivotal Phase III 60 randomized clinical